News View all news
ALS patients losing time and hope as they wait for insurers to cover a pricey new drug
Many ALS patients cannot afford the $145,000 price of the drug edavarone (Radicava—Mitsubishi Tanabe) without insurance, but some insurance provider have denied access to the drug, even though it was approved by FDA last fall for treatment of the disease.
May 21, 2018
Want to be more effective, smarter, and better liked? Ask more…
I recently read a piece called The Surprising Power of Questions in the May–June 2018 issue of Harvard Business Review. It caused me to reflect on how I interact with folks. I’m sure I could do a…0 comments
May 8, 2018
Pharmacists to Serve on Health and Human Services (HHS) Pain Management Task Force
The Task Force will hold its inaugural public meeting on May 30, 2018, from 9:30 a.m. to 5:00 p.m. ET, and on May 31, 2018, from 9:00 a.m. to 3:30 p.m. ET.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.